The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus
Open accessAbstract
Hepatitis C virus (HCV) infects nearly 3% of the population of the world and is a major cause of liver disease. However, the mechanism whereby the virus targets the liver for infection remains unknown, because none of the putative cellular receptors for HCV are both expressed specifically in the liver and capable of binding HCV envelope glycoproteins. Liver/lymph node-specific intercellular adhesion molecule-3-grabbing integrin (L-SIGN) is a calcium-dependent lectin expressed on endothelial cells of liver and lymph nodes. Dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN), a homologous molecule expressed on dendritic cells, binds HIV and promotes infection. By using a virus-binding assay, we demonstrate that L-SIGN and DC-SIGN specifically bind naturally occurring HCV present in the sera of infected individuals. Further studies demonstrate that binding is mediated by the HCV envelope glycoprotein E2 and is blocked by specific inhibitors, including mannan, calcium chelators, and Abs to the lectin domain of the SIGN molecules. Thus, L-SIGN represents a liver-specific receptor for HCV, and L-SIGN and DC-SIGN may play important roles in HCV infection and immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Lauer, G. M., & Walker, B. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450107 · Cited by 2,973
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
Geijtenbeek, T. B. H., Kwon, D. S., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C. F., Middel, J., Cornelissen, I. L. M. H. A., Nottet, H. S. L. M., KewalRamani, V. N., Littman, D. R., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)80694-7 · Cited by 2,447
Binding of Hepatitis C Virus to CD81
Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A. J., Houghton, M., Rosa, D., Grandi, G., et al. (1998) · Science · doi:10.1126/science.282.5390.938 · Cited by 2,066
Geijtenbeek, T. B. H., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C. F., Adema, G. J., van Kooyk, Y., & Figdor, C. G. (2000) · Cell · doi:10.1016/s0092-8674(00)80693-5 · Cited by 1,700
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
Scarselli, E., Ansuini, H., Cerino, R., Roccasecca, R. M., Acali, S., Filocamo, G., Traboni, C., Nicosia, A., Cortese, R., & Vitelli, A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf529 · Cited by 1,177
Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor
Agnello, V., Ábel, G., Elfahal, M., Knight, G. B., & Zhang, Q.-X. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12766 · Cited by 974
Limmer, A., Ohl, J., Kurts, C., Ljunggren, H.-G., Reiss, Y., Groettrup, M., Momburg, F., Arnold, B., & Knolle, P. A. (2000) · Nature Medicine · doi:10.1038/82161 · Cited by 758
Structural Basis for Selective Recognition of Oligosaccharides by DC-SIGN and DC-SIGNR
Feinberg, H., Mitchell, D. A., Drickamer, K., & Weis, W. I. (2001) · Science · doi:10.1126/science.1066371 · Cited by 676
C-Type Lectins DC-SIGN and L-SIGN Mediate Cellular Entry by Ebola Virus in cis and in trans
Alvarez, C. P., Lasala, F., Carrillo, J., Muñiz, O., Corbí, A. L., & Delgado, R. (2002) · Journal of Virology · doi:10.1128/jvi.76.13.6841-6844.2002 · Cited by 652
Engering, A., Geijtenbeek, T. B. H., van Vliet, S. J., Wijers, M., van Liempt, E., Demaurex, N., Lanzavecchia, A., Fransen, J., Figdor, C. G., Piguet, V., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2118 · Cited by 630
Local control of the immune response in the liver
Knolle, P. A., & Gerken, G. (2000) · Immunological Reviews · doi:10.1034/j.1600-0528.2002.017408.x · Cited by 603
DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection
Kwon, D. S., Gregorio, G., Bitton, N., Hendrickson, W. A., & Littman, D. R. (2002) · Immunity · doi:10.1016/s1074-7613(02)00259-5 · Cited by 523
A Novel Mechanism of Carbohydrate Recognition by the C-type Lectins DC-SIGN and DC-SIGNR
Mitchell, D. A., Fadden, A. J., & Drickamer, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104565200 · Cited by 502
Dissecting virus entry via endocytosis
Sieczkarski, S. B., & Whittaker, G. R. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-7-1535 · Cited by 487
Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection
Bain, C., Fatmi, A., Zoulim, F., Zarski, J.-P., Trépo, C., & Inchauspé, G. (2001) · Gastroenterology · doi:10.1053/gast.2001.21212 · Cited by 410
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
Pöhlmann, S., Zhang, J., Baribaud, F., Chen, Z., Leslie, G. J., Lin, G., Granelli-Piperno, A., Doms, R. W., Rice, C. M., & McKeating, J. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4070-4080.2003 · Cited by 389
DC-SIGN and L-SIGN Are High Affinity Binding Receptors for Hepatitis C Virus Glycoprotein E2
Lozach, P.-Y., Lortat-Jacob, H., De Lacroix De Lavalette, A., Staropoli, I., Foung, S., Amara, A., Houlès, C., Fieschi, F., Schwartz, O., Virelizier, J.-L., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301284200 · Cited by 375
Bashirova, A. A., Geijtenbeek, T. B. H., van Duijnhoven, G. C. F., van Vliet, S. J., Eilering, J. B. G., Martin, M. P., Wu, L., Martin, T. D., Viebig, N., Knolle, P. A., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.671 · Cited by 358
Kanto, T., Hayashi, N., Takehara, T., Tatsumi, T., Kuzushita, N., Ito, A., Sasaki, Y., Kasahara, A., & Hori, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5584 · Cited by 356
Halary, F., Amara, A., Lortat-Jacob, H., Messerle, M., Delaunay, T., Houlès, C., Fieschi, F., Arenzana-Seisdedos, F., Moreau, J.-F., & Déchanet-Merville, J. (2002) · Immunity · doi:10.1016/s1074-7613(02)00447-8 · Cited by 356
Pöhlmann, S., Soilleux, E. J., Baribaud, F., Leslie, G. J., Morris, L. S., Trowsdale, J., Lee, B., Coleman, N., & Doms, R. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051631398 · Cited by 324
Effect of glycosylation on antibody function: implications for genetic engineering
Wright, A., & Morrison, S. L. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(96)10062-7 · Cited by 312
Auffermann-Gretzinger, S., Keeffe, E. B., & Levy, S. (2001) · Blood · doi:10.1182/blood.v97.10.3171 · Cited by 304
Doms, R. W., & Moore, J. P. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.2.f9 · Cited by 296
Young, K. K., Resnick, R. M., & Myers, T. W. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.4.882-886.1993 · Cited by 289
Jameson, B., Baribaud, F., Pöhlmann, S., Ghavimi, D., Mortari, F., Doms, R. W., & Iwasaki, A. (2002) · Journal of Virology · doi:10.1128/jvi.76.4.1866-1875.2002 · Cited by 264
Geijtenbeek, T. B. H., van Duijnhoven, G. C. F., van Vliet, S. J., Krieger, E., Vriend, G., Figdor, C. G., & van Kooyk, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111532200 · Cited by 181
Lee, B., Leslie, G., Soilleux, E., O'Doherty, U., Baik, S., Levroney, E., Flummerfelt, K., Swiggard, W., Coleman, N., Malim, M., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12028-12038.2001 · Cited by 181
Dammacco, F., Sansonno, D. E., Piccoli, C., Racanelli, V., D’Amore, F. P., & Lauletta, G. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9613 · Cited by 165
Colmenares, M., Puig-Kröger, A., Pello, O. M., Corbı́, A. L., & Rivas, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205270200 · Cited by 162
Breiner, K. M., Schaller, H., & Knolle, P. (2001) · Hepatology · doi:10.1053/jhep.2001.27810 · Cited by 134
Folding, Assembly and Subcellular Localization of Hepatitis C Virus Glycoproteins
Dubuisson, J. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59605-6_7 · Cited by 124
Wu, L. J., Martin, T. D., Vazeux, R., Unutmaz, D., & KewalRamani, V. N. (2002) · Journal of Virology · doi:10.1128/jvi.76.12.5905-5914.2002 · Cited by 119
Baribaud, F., Pöhlmann, S., Leslie, G. J., Mortari, F., & Doms, R. W. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9135-9142.2002 · Cited by 103
Dendritic cell susceptibility to hepatitis C virus genotype 1 infection
Navas, M. C., Fuchs, A., Schvoerer, É., Bohbot, A., Aubertin, A.-M., & Stoll‐Keller, F. (2002) · Journal of Medical Virology · doi:10.1002/jmv.2204 · Cited by 98
Hong, P. W.-P., Flummerfelt, K. B., de Parseval, A., Gurney, K. B., Elder, J. H., & Lee, B. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.12855-12865.2002 · Cited by 96
Frankel, S. S., Steinman, R. M., Michael, N. L., Ratto‐Kim, S., Bhardwaj, N., Pope, M., Louder, M. K., Ehrenberg, P. K., Parren, P. W. H. I., Burton, D. R., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9788-9794.1998 · Cited by 92
Liver endothelium mediates the hepatocyte's uptake of ceruloplasmin.
Tavassoli, M., Kishimoto, T., & Kataoka, M. (1986) · The Journal of Cell Biology · doi:10.1083/jcb.102.4.1298 · Cited by 85
The role of the hepatitis C virus glycoproteins in infection
Flint, M., & McKeating, J. A. (2000) · Reviews in Medical Virology · doi:10.1002/(sici)1099-1654(200003/04)10:2<101::aid-rmv268>3.0.co;2-w · Cited by 84
Cited by
DC-SIGN: escape mechanism for pathogens
van Kooyk, Y., & Geijtenbeek, T. B. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1182 · Cited by 928
IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS
Guidotti, L. G., & Chisari, F. V. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100230 · Cited by 811
Bartosch, B., Vitelli, A., Granier, C., Goujon, C., Dubuisson, J., Pascale, S., Scarselli, E., Cortese, R., Nicosia, A., & Cosset, F.-L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305289200 · Cited by 631
Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis
Blanchard, E., Belouzard, S., Goueslain, L., Wakita, T., Dubuisson, J., Wychowski, C., & Rouillé, Y. (2006) · Journal of Virology · doi:10.1128/jvi.00024-06 · Cited by 599
Living in the liver: hepatic infections
Protzer, U., Maini, M. K., & Knolle, P. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3169 · Cited by 560
Metadata
- Authors
- Gardner, J. P., Durso, R. J., Arrigale, R. R., Donovan, G. P., Maddon, P. J., Dragic, T., & Olson, W. C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-04-03
- Volume
- 100
- Issue
- 8
- Pages
- 4498-4503
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2052588752
- Cited by
- 306
- References
- 40
- FWCI
- 21.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.